Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Potentially modifiable risk factors including obesity, diabetes, hypertension, and smoking are associated with Alzheimer disease (AD) and represent promising targets for intervention. However, the causality of these associations is unclear. We sought to assess the causal nature of these associations using Mendelian randomization (MR). METHODS AND FINDINGS: We used SNPs associated with each risk factor as instrumental variables in MR analyses. We considered type 2 diabetes (T2D, NSNPs = 49), fasting glucose (NSNPs = 36), insulin resistance (NSNPs = 10), body mass index (BMI, NSNPs = 32), total cholesterol (NSNPs = 73), HDL-cholesterol (NSNPs = 71), LDL-cholesterol (NSNPs = 57), triglycerides (NSNPs = 39), systolic blood pressure (SBP, NSNPs = 24), smoking initiation (NSNPs = 1), smoking quantity (NSNPs = 3), university completion (NSNPs = 2), and years of education (NSNPs = 1). We calculated MR estimates of associations between each exposure and AD risk using an inverse-variance weighted approach, with summary statistics of SNP-AD associations from the International Genomics of Alzheimer's Project, comprising a total of 17,008 individuals with AD and 37,154 cognitively normal elderly controls. We found that genetically predicted higher SBP was associated with lower AD risk (odds ratio [OR] per standard deviation [15.4 mm Hg] of SBP [95% CI]: 0.75 [0.62-0.91]; p = 3.4 × 10(-3)). Genetically predicted higher SBP was also associated with a higher probability of taking antihypertensive medication (p = 6.7 × 10(-8)). Genetically predicted smoking quantity was associated with lower AD risk (OR per ten cigarettes per day [95% CI]: 0.67 [0.51-0.89]; p = 6.5 × 10(-3)), although we were unable to stratify by smoking history; genetically predicted smoking initiation was not associated with AD risk (OR = 0.70 [0.37, 1.33]; p = 0.28). We saw no evidence of causal associations between glycemic traits, T2D, BMI, or educational attainment and risk of AD (all p > 0.1). Potential limitations of this study include the small proportion of intermediate trait variance explained by genetic variants and other implicit limitations of MR analyses. CONCLUSIONS: Inherited lifetime exposure to higher SBP is associated with lower AD risk. These findings suggest that higher blood pressure--or some environmental exposure associated with higher blood pressure, such as use of antihypertensive medications--may reduce AD risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig 1 Mendelian randomization estimates of the association of systolic blood pressure with AD in individual ADGC studies and overall in ADGC, GERAD1, and IGAP. This figure shows MR estimates for the association of SBP-associated variants with AD in each of the participant studies in ADGC [24] and in GERAD1 [25] using individual SNP-level data compared to that observed in IGAP [12] using summary-level data. See S1 Text (supplemental results) for individual study name abbreviations.](https://figures.cochat.ai/paper-figures/93ec1ed369514e09ab69e37cc379cde9/associations-between-potentially-modifiable-risk-factors-and-alzheimer-disease-a-figure-1.jpg)
![Fig 2 Associations of the systolic blood pressure genetic score with quantitative traits in the EPIC-InterAct study. This figure shows the investigation of pleiotropic associations of genetic score for SBP with quantitative traits in the EPIC-InterAct study [26]. Effect sizes are expressed in SDs per SBP-raising allele. Analyses were adjusted for age, sex, center of recruitment, and subcohort status.](https://figures.cochat.ai/paper-figures/77208328cad54e2fb95f55e3d441e7ff/associations-between-potentially-modifiable-risk-factors-and-alzheimer-disease-a-figure-2.jpg)
![Fig 3 Association of the systolic blood pressure genetic score with systolic blood pressure by age stratum in the EPIC-InterAct subcohort. This figure shows the association between the genetic score for SBP and SBP in the EPIC-InterAct study by age stratum [26]. Analyses were adjusted for sex, center of recruitment, and subcohort status.](https://figures.cochat.ai/paper-figures/a6202231a2e1419b901bfc75dd8209c6/associations-between-potentially-modifiable-risk-factors-and-alzheimer-disease-a-figure-3.jpg)
![Fig 4 Associations of the systolic blood pressure genetic score with binary outcomes in the EPIC-InterAct study. This figure shows the investigation of pleiotropic associations of the genetic score for SBP with binary outcomes in the EPIC-InterAct study [26]. The OR per SBP-raising allele is shown.](https://figures.cochat.ai/paper-figures/f0f543d70ce04999b366a54a31fbe5d0/associations-between-potentially-modifiable-risk-factors-and-alzheimer-disease-a-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting previous research suggesting that use of blood pressure and diabetic medications may reduce the risk of Alzheimer’s disease120.”
From Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) · cites this paper as [120]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Their interpretation was that increased risk in the weight loss group was due to reverse causation, as people often lose weight before they develop dementia.”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [193]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“An IPD meta-analysis of 1.3 million people from 39 prospective cohort studies found that obesity was a risk factor for dementia in cohorts where baseline was >15 years before but appeared protective if <10 before dementia. 193”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [193]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · cited 1×
“Rather, the well-established association of APOE haplotypes with AD risk [47] implicates APOE itself as a key causal factor in the etiology of AD.”
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
Faith, M. S., Carnell, S., & Kral, T. V. E. (2013) · Human Heredity · doi:10.1159/000353879 · Cited by 7,601
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882 · cited 1×
“One method for estimating the causal effects of risk factors with known genetic determinants is Mendelian randomization (MR) [11].”
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941 · cited 1×
“Alzheimer disease (AD) prevalence is rising [1], further increasing the social and economic burden of this disease [2].”
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · cited 17×
“SNPs included in each risk score, their associations estimated by the relevant consortium, and their association with AD (IGAP [12]).”
InfluentialSelf-citationHearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
Cited by
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Self-citationAlzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946
Self-citationIadecola, C., Yaffe, K., Biller, J., Bratzke, L. C., Faraci, F. M., Gorelick, P. B., Gulati, M., Kamel, H., Knopman, D. S., Launer, L. J., et al. (2016) · Hypertension · doi:10.1161/hyp.0000000000000053 · Cited by 746
Neurovascular and Cognitive Dysfunction in Hypertension: Epidemiology, Pathobiology, and Treatment
Iadecola, C., & Gottesman, R. F. (2019) · Circulation Research · doi:10.1161/circresaha.118.313260 · Cited by 502
Lotta, L. A., Scott, R. A., Sharp, S. J., Burgess, S., Luan, J., Tillin, T., Schmidt, A. F., Imamura, F., Stewart, I. D., Perry, J. R. B., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002179 · Cited by 417
Self-citationObesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II study
Singh‐Manoux, A., Dugravot, A., Shipley, M., Brunner, E. J., Elbaz, A., Sabia, S., & Kivimaki, M. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.06.2637 · Cited by 401
“The second set of studies was based on aMendelian randomization (MR) approach, which uses genetic variants as proxies for exposures, to show no association between obesity and dementia [10,11].”
BackgroundModifiable pathways in Alzheimer’s disease: Mendelian randomisation analysis
Larsson, S. C., Traylor, M., Malik, R., Dichgans, M., Burgess, S., & Markus, H. S. (2017) · BMJ · doi:10.1136/bmj.j5375 · Cited by 382
Biomarkers for Alzheimer's Disease Diagnosis
Mantzavinos, V., & Alexiou, A. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170203125942 · Cited by 295
Tynkkynen, J., Chouraki, V., van der Lee, S. J., Hernesniemi, J., Yang, Q., Li, S., Beiser, A., Larson, M. G., Sääksjärvi, K., Shipley, M. J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.01.003 · Cited by 272
Noyce, A. J., Kia, D. A., Hemani, G., Nicolas, A., Price, T. R., De Pablo-Fernandez, E., Haycock, P. C., Lewis, P. A., Foltynie, T., Davey Smith, G., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002314 · Cited by 175
Higher risk of dementia in English older individuals who are overweight or obese
Ma, Y., Ajnakina, O., Steptoe, A., & Cadar, D. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa099 · Cited by 172
Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach
Cholerton, B., Baker, L. D., Montine, T. J., & Craft, S. (2016) · Diabetes Spectrum · doi:10.2337/ds16-0041 · Cited by 170
Malik, R., Georgakis, M. K., Neitzel, J., Rannikmäe, K., Ewers, M., Seshadri, S., Sudlow, C. L. M., & Dichgans, M. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12320 · Cited by 167
Common Methods for Performing Mendelian Randomization
Teumer, A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00051 · Cited by 165
Causal associations between modifiable risk factors and the Alzheimer's phenome
Andrews, S. J., Fulton‐Howard, B., O'Reilly, P., Marcora, E., Goate, A. M., & collaborators of the Alzheimer's Disease Genetics Consortium (2021) · Annals of Neurology · doi:10.1002/ana.25918 · Cited by 156
“AD risk.(51) Second, Larsson and colleagues evaluated the association of 22 risk factors with AD, finding that years of education, intelligence, and 25-hydroxyvitamin D were associated with a reduced risk of AD, whereas coffee consumption was associated with increased risk.”
BackgroundLipid lowering and Alzheimer disease risk: A mendelian randomization study
Williams, D. M., Finan, C., Schmidt, A. F., Burgess, S., & Hingorani, A. D. (2020) · Annals of Neurology · doi:10.1002/ana.25642 · Cited by 157
Burgess, S., & Davey Smith, G. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.03.042 · Cited by 152
Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer’s disease
Broce, I. J., Tan, C. H., Fan, C. C., Jansen, I., Savage, J. E., Witoelar, A., Wen, N., Hess, C. P., Dillon, W. P., Glastonbury, C. M., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1928-6 · Cited by 140
Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease
Nordestgaard, L. T., Christoffersen, M., & Frikke‐Schmidt, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179777 · Cited by 141
Schilling, S., Tzourio, C., Soumaré, A., Kaffashian, S., Dartigues, J.-F., Ancelin, M.-L., Samieri, C., Dufouil, C., & Debette, S. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002265 · Cited by 119
HDL from an Alzheimer's disease perspective
Button, E. B., Robert, J., Caffrey, T. M., Fan, J., Zhao, W., & Wellington, C. L. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000604 · Cited by 114
Genetically decreased vitamin D and risk of Alzheimer disease
Mokry, L. E., Ross, S. A., Morris, J. A., Manousaki, D., Forgetta, V., & Richards, J. B. (2016) · Neurology · doi:10.1212/wnl.0000000000003430 · Cited by 119
Serum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers
Bernath, M. M., Bhattacharyya, S., Nho, K., Barupal, D. K., Fiehn, O., Baillie, R., Risacher, S. L., Arnold, M., Jacobson, T., Trojanowski, J. Q., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009436 · Cited by 113
Emdin, C. A., Rothwell, P. M., Salimi-Khorshidi, G., Kiran, A., Conrad, N., Callender, T., Mehta, Z., Pendlebury, S. T., Anderson, S. G., Mohseni, H., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.012658 · Cited by 111
Genetics of substance use disorders in the era of big data
Gelernter, J., & Polimanti, R. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00377-1 · Cited by 107
Forcano, L., Mata, F., de la Torre, R., & Verdejo‐García, A. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.003 · Cited by 109
Gabin, J. M., Tambs, K., Saltvedt, I., Sund, E., & Holmen, J. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0262-x · Cited by 99
Walker, V. M., Kehoe, P. G., Martin, R. M., & Davies, N. M. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyz155 · Cited by 96
Walker, V. M., Kehoe, P. G., Martin, R. M., & Davies, N. M. (2018) · doi:10.1101/486878 · Cited by 96
Zeng, P., Wang, T., Zheng, J., & Zhou, X. (2019) · BMC Medicine · doi:10.1186/s12916-019-1448-9 · Cited by 95
Treur, J. L., Munafo, M. R., Logtenberg, E., Wiers, R. W. H. J., & Verweij, K. J. H. (2021) · Psychological Medicine · doi:10.1017/s003329172100180x · Cited by 112
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease
Luo, J. M., Thomassen, J. Q., Bellenguez, C., Grenier‐Boley, B., de Rojas, I., Castillo-Morales, A., Parveen, K., Küçükali, F., Nicolas, A., Peters, O., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.13734 · Cited by 114
Alzheimer’s disease – the journey of a healthy brain into organ failure
Golde, T. E. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00523-1 · Cited by 88
Sproviero, W., Winchester, L., Newby, D., Fernandes, M., Shi, L., Goodday, S. M., Prats-Uribe, A., Alhambra, D. P., Buckley, N. J., & Nevado-Holgado, A. J. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.12.015 · Cited by 86
Winchester, L. M., Powell, J. F., Lovestone, S., & Nevado‐Holgado, A. J. (2018) · Genome Medicine · doi:10.1186/s13073-018-0556-z · Cited by 88
Self-citationPlasma high-density lipoprotein cholesterol and risk of dementia: observational and genetic studies
Kjeldsen, E. W., Thomassen, J. Q., Rasmussen, I. J., Nordestgaard, B. G., Tybjærg‐Hansen, A., & Frikke‐Schmidt, R. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab164 · Cited by 91
Dimache, A.-M., Șalaru, D. L., Sascău, R. A., & Stătescu, C. (2021) · Nutrients · doi:10.3390/nu13062118 · Cited by 89
Association between alcohol consumption and Alzheimer's disease: A Mendelian randomization study
Andrews, S. J., Goate, A., & Anstey, K. J. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.09.086 · Cited by 82
Thomassen, J. Q., Tolstrup, J. S., Benn, M., & Frikke‐Schmidt, R. (2020) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796020000347 · Cited by 92
The Role of Genetics in Advancing Precision Medicine for Alzheimer’s Disease—A Narrative Review
Freudenberg-Hua, Y., Li, W., & Davies, P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00108 · Cited by 74
HDL Cholesterol and Non-Cardiovascular Disease: A Narrative Review
Kjeldsen, E. W., Nordestgaard, L. T., & Frikke‐Schmidt, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094547 · Cited by 81
Pillai, J. A., Bena, J., Bekris, L. M., Kodur, N., Kasumov, T., Leverenz, J. B., Kashyap, S. R., & Initiative, O. B. O. T. A. D. N. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01203-y · Cited by 76
Korologou-Linden, R., Bhatta, L., Brumpton, B. M., Howe, L. D., Millard, L. A. C., Kolaric, K., Ben-Shlomo, Y., Williams, D. M., Smith, G. D., Anderson, E. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32183-6 · Cited by 71
Nordestgaard, L. T., Tybjærg-Hansen, A., Nordestgaard, B. G., & Frikke-Schmidt, R. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00195 · Cited by 68
Mendelian randomisation for nutritional psychiatry
Carnegie, R., Zheng, J., Sallis, H., Jones, H. J., Wade, K. H., Evans, J., Zammit, S., Munafo, M. R., & Martin, R. M. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30293-7 · Cited by 73
Zahodne, L. B., Mayeda, E. R., Hohman, T. J., Fletcher, E., Racine, A. M., Gavett, B. E., Manly, J. J., Schupf, N., Mayeux, R. P., Brickman, A. M., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.009 · Cited by 77
Zhu, Z., Lin, Y., Li, X., Driver, J. A., & Liang, L. (2019) · Human Genetics · doi:10.1007/s00439-019-01988-9 · Cited by 85
Midlife lipid and glucose levels are associated with Alzheimer's disease
Zhang, X., Tong, T., Chang, A., Ang, T. F. A., Tao, Q., Auerbach, S., Devine, S., Qiu, W. Q., Mez, J., Massaro, J., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12641 · Cited by 65
Lord, J., Jermy, B., Green, R., Wong, A., Xu, J., Legido-Quigley, C., Dobson, R., Richards, M., & Proitsi, P. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009808118 · Cited by 63
Self-citationThe Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease
Tosto, G., Bird, T. D., Bennett, D. A., Boeve, B. F., Brickman, A. M., Cruchaga, C., Faber, K., Foroud, T. M., Farlow, M., Goate, A. M., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2539 · Cited by 62
RAB10: an Alzheimer’s disease resilience locus and potential drug target
Tavana, J., Rosene, M., Jensen, N., Ridge, P. G., Kauwe, J. S. K., & Karch, C. M. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s159148 · Cited by 62
Self-citationA Bayesian Model for the Prediction and Early Diagnosis of Alzheimer's Disease
Alexiou, A. T., Vasileios, M., Greig, N. H., & Kamal, M. A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00077 · Cited by 71
Kuźma, E., Hannon, E., Zhou, A., Lourida, I., Bethel, A., Levine, D. A., Lunnon, K., Thompson-Coon, J., Hyppönen, E., & Llewellyn, D. J. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180013 · Cited by 59
Blood Pressure Control and Dementia Risk in Midlife Patients With Atrial Fibrillation
Kim, D., Yang, P., Jang, E., Yu, H. T., Kim, T., Uhm, J., Kim, J., Sung, J., Pak, H., Lee, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14388 · Cited by 65
Yang, Q., Borges, M. C., Sanderson, E. C. M., Magnus, M. C., Kilpi, F., Collings, P. J., Soares, A. G., West, J., Magnus, P. M., Wright, J., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1004090 · Cited by 63
High Hemoglobin A1c and Diabetes Predict Memory Decline in the Health and Retirement Study
Marden, J. R., Mayeda, E. R., Tchetgen, E. J. T., Kawachi, I. I., & Glymour, M. M. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000182 · Cited by 64
Zeng, P., & Zhou, X. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00618 · Cited by 68
Jia, J., Xu, J. L., Liu, J., Wang, Y., Wang, Y., Cao, Y., Guo, Q., Qu, Q.-M., Wei, C., Wei, W., et al. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00701-z · Cited by 63
Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia
Rasmussen, I. J., & Frikke‐Schmidt, R. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad293 · Cited by 61
Hussain, S. M., Robb, C. E., Tonkin, A. M., Lacaze, P. A., Chong, T. T. ‐., Beilin, L. J., Yu, C., Watts, G. F., Ryan, J. L., Ernst, M. E., et al. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100963 · Cited by 69
Seblova, D., Fischer, M., Fors, S., Johnell, K., Karlsson, M., Nilsson, T., Svensson, A. C., Lövdén, M., & Lager, A. (2021) · American Journal of Epidemiology · doi:10.1093/aje/kwaa255 · Cited by 48
Impact of glucose on risk of dementia: Mendelian randomisation studies in 115,875 individuals
Benn, M., Nordestgaard, B. G., Tybjærg‐Hansen, A., & Frikke‐Schmidt, R. (2020) · Diabetologia · doi:10.1007/s00125-020-05124-5 · Cited by 47
Makizako, H., Shimada, H., Doi, T., Tsutsumimoto, K., Hotta, R., Nakakubo, S., Makino, K., & Suzuki, T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160244 · Cited by 50
Garfield, V., Farmaki, A., Fatemifar, G., Eastwood, S. V., Mathur, R., Rentsch, C. T., Denaxas, S., Bhaskaran, K., Smeeth, L. L., & Chaturvedi, N. (2021) · Diabetes · doi:10.2337/db20-0895 · Cited by 47
Causal inference in obesity research
Franks, P. W., & Atabaki‐Pasdar, N. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12577 · Cited by 53
The pleiotropic vasoprotective functions of high density lipoproteins (HDL)
Guilaine, B., Emily, B., Sonja, S., & Cheryl, W. (2018) · The Journal of Biomedical Research · doi:10.7555/jbr.31.20160103 · Cited by 41
Cho, G. J., Hwang, S. Y., Lee, K., Choi, K. M., Baik, S. H., Kim, T., Han, S. W., & Yoo, H. J. (2019) · Obesity · doi:10.1002/oby.22609 · Cited by 43
Unified theory of Alzheimer’s disease (UTAD): implications for prevention and curative therapy
Nehls, M. (2016) · Journal of Molecular Psychiatry · doi:10.1186/s40303-016-0018-8 · Cited by 41
“for developing AD [261].”
Program, T. V. M. V., Bone, W. P., Siewert, K. M., Jha, A., Klarin, D., Damrauer, S. M., Chang, K.-M., Tsao, P. S., Assimes, T. L., Ritchie, M. D., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00773-z · Cited by 41
Mendelian randomization study of diabetes and dementia in the Million Veteran Program
LITKOWSKI, E. M., Logue, M. W., Zhang, R., CHAREST, B. R., Lange, E. M., Hokanson, J. E., Lynch, J. A., Vujković, M., Phillips, L. S., Hauger, R. L., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13373 · Cited by 44
Thirunavu, V. M., McCullough, A. A., Su, Y., Flores, S. E., Dincer, A., Morris, J. C., Cruchaga, C., Benzinger, T. L. S., & Gordon, B. A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190154 · Cited by 40
microRNA-Based Biomarkers and the Diagnosis of Alzheimer’s Disease
Zhao, Y., Bhattacharjee, S., Dua, P., Alexandrov, P. N., & Lukiw, W. J. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00162 · Cited by 35
Re-thinking Alzheimer's disease therapeutic targets using gene-based tests
Kwok, M. K., Lin, S. L., & Schooling, C. M. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.001 · Cited by 35
Associations between vascular risk factors and subsequent Alzheimer’s disease in older adults
Lee, H., Kim, K., Lee, Y. C., Kim, S., Won, H., Yu, T. Y., Lee, E. M., Kang, J. M., Lewis, M., Kim, D. K., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00690-7 · Cited by 42
Associations of hypertension burden on subsequent dementia: a population-based cohort study
Jung, H., Yang, P., Kim, D., Jang, E., Yu, H. T., Kim, T., Sung, J., Pak, H., Lee, M., Lip, G. Y. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91923-8 · Cited by 45
Genomic variation in educational attainment modifies Alzheimer disease risk
Raghavan, N. S., Vardarajan, B., & Mayeux, R. (2019) · Neurology Genetics · doi:10.1212/nxg.0000000000000310 · Cited by 33
Ou, Y., Yang, Y., Shen, X., Ma, Y., Chen, S.-D., Dong, Q., Tan, L., & Yu, J. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00782-y · Cited by 35
Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study
Walter, S., Marden, J. R., Kubzansky, L. D., Mayeda, E. R., Crane, P. K., Chang, S., Cornelis, M. C., Rehkopf, D. H., Mukherjee, S., & Glymour, M. M. (2015) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000128 · Cited by 36
Self-citationArtificial intelligence for dementia genetics and omics
Bettencourt, C., Skene, N., Bandres‐Ciga, S., Anderson, E., Winchester, L. M., Foote, I. F., Schwartzentruber, J., Botia, J. A., Nalls, M., Singleton, A., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13427 · Cited by 30
Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease
Zhao, Y., Alexandrov, P. N., & Lukiw, W. J. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00059 · Cited by 30
Doney, A. S. F., Bonney, W., Jefferson, E., Walesby, K. E., Bittern, R., Trucco, E., Connelly, P., McCrimmon, R. J., & Palmer, C. N. A. (2019) · Diabetes Care · doi:10.2337/dc19-0380 · Cited by 30
Amyloid, tau and risk of Alzheimer’s disease: a Mendelian randomization study
Yeung, C. H. C., Lau, K. W. D., Yeung, S. L. A., & Schooling, C. M. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00683-8 · Cited by 29
Telomere length and health outcomes: A two-sample genetic instrumental variables analysis
Hamad, R., Walter, S., & Rehkopf, D. H. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.06.005 · Cited by 31
Self-citationImpact of vitamin D receptor polymorphisms in centenarians
Gussago, C., Arosio, B., Guerini, F. R., Ferri, E., Costa, A. S., Casati, M., Bollini, E. M., Ronchetti, F., Colombo, E. V., Bernardelli, G., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0908-7 · Cited by 34
A Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction
Merino, J., Udler, M. S., Leong, A., & Meigs, J. B. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0958-0 · Cited by 35
Causal cardiovascular risk factors for dementia: insights from observational and genetic studies
Kjeldsen, E. W., & Frikke‐Schmidt, R. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae235 · Cited by 39
Lifetime cognition and late midlife blood metabolites: findings from a British birth cohort
Proitsi, P., Kuh, D. J., Wong, A., Maddock, J., Bendayan, R., Wulaningsih, W., Hardy, R., & Richards, M. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0253-0 · Cited by 31
Self-citationDybjer, E., Kumar, A., Nägga, K., Engström, G., Mattsson, N., Nilsson, P. M., Melander, O., & Hansson, O. (2023) · Brain Communications · doi:10.1093/braincomms/fcad054 · Cited by 30
Zhou, M., Li, H., Wang, Y., Pan, Y., & Wang, Y. (2021) · European Journal of Neurology · doi:10.1111/ene.15190 · Cited by 25
Mulugeta, A., Lumsden, A. L., & Hyppönen, E. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.02.010 · Cited by 26
Are large simple trials for dementia prevention possible?
Whiteley, W. N., Anand, S., Bangdiwala, S. I., Bosch, J., Canavan, M., Chertkow, H., Gerstein, H. C., Gorelick, P., O’Donnell, M., Paré, G., et al. (2020) · Age and Ageing · doi:10.1093/ageing/afz152 · Cited by 23
Ware, E. B., Morataya, C., Fu, M., & Bakulski, K. M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.634767 · Cited by 27
He, L., Culminskaya, I. V., Loika, Y., Arbeev, K. G., Bagley, O., Duan, M., Yashin, A. I., & Kulminski, A. M. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.09.019 · Cited by 22
Circulating insulin-like growth factors and Alzheimer disease: A mendelian randomization study
Williams, D. M., Karlsson, I., Pedersen, N. L., & Hägg, S. (2017) · Neurology · doi:10.1212/wnl.0000000000004854 · Cited by 25
Association of blood pressure with cognitive function at midlife: a Mendelian randomization study
Sun, D., Thomas, E. A., Launer, L. J., Sidney, S., Yaffe, K. S., & Fornage, M. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-00769-y · Cited by 25
Glycemic traits and Alzheimer’s disease: a mendelian randomization study
Pan, Y., Chen, W., Yan, H., Wang, M., & Xiang, X. (2020) · Aging · doi:10.18632/aging.103887 · Cited by 44
Genetic Complexities of Cerebral Small Vessel Disease, Blood Pressure, and Dementia
Sargurupremraj, M., Soumaré, A., Bis, J. C., Surakka, I. L., Jürgenson, T., Joly, P., Knol, M. J., Wang, R., Yang, Q., Satizábal, C. L., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.12824 · Cited by 27
Huang, S.-Y., Yang, Y.-X., Zhang, Y.-R., Kuo, K., Li, H.-Q., Shen, X.-N., Chen, S.-D., Chen, K.-L., Dong, Q., Tan, L., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220050 · Cited by 23
Fast numerical optimization for genome sequencing data in population biobanks
Li, R., Chang, C. C., Tanigawa, Y., Narasimhan, B., Hastie, T. J., Tibshirani, R. J., & Rivas, M. A. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab452 · Cited by 21
Yu, N., Wang, J., Liu, Y., & Guo, Y. (2023) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbad023 · Cited by 21
Metadata
- Authors
- Østergaard, S. D., Mukherjee, S., Sharp, S. J., Proitsi, P., Lotta, L. A., Day, F., Perry, J. R. B., Boehme, K. L., Walter, S., Kauwe, J. S., Gibbons, L. E., Alzheimer’s Disease Genetics Consortium, The GERAD1 Consortium, EPIC-InterAct Consortium, Larson, E. B., Powell, J. F., Langenberg, C., Crane, P. K., Wareham, N. J., & Scott, R. A.
- Affiliations
- Aarhus University (DK)
- University of Washington (US)
- University of Cambridge (GB)
- King's College London (GB)
- Brigham Young University (US)
- University of California, San Francisco (US)
- Kaiser Permanente Washington Health Research Institute (US)
- Corresponding author
- Scott, Robert A.
- ORCID
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-06-16
- Volume
- 12
- Issue
- 6
- Pages
- e1001841
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC4469461
- OpenAlex
- W605291159
- Cited by
- 203
- References
- 51
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 15 · 2023: 17 · 2022: 16 · 2021: 36 · 2020: 23 · 2019: 23 · 2018: 17 · 2017: 17 · 2016: 13 · 2015: 4
- FWCI
- 13.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Research Portal (Queen's University Belfast) (submittedVersion, cc-by)
- DiVA at Umeå University (Umeå University) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Site cant be reached (submittedVersion, cc-by)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Funders
- Howard Hughes Medical Institute
- U.S. Department of Veterans Affairs (U01 AG024904)
- Juvenile Diabetes Research Foundation International
- Alzheimer's Association (IIRG-05–14147, K01 AG030514, U01 AG016976, U01 AG032984, IIRG-08-89720, U01 AG024904, U24AG021886)
- Dana Foundation (K01 AG030514, U01 AG024904)
- Bristol-Myers Squibb (U01 AG024904, AG024904)
- Eli Lilly and Company (U01 AG024904, AG024904)
- Pfizer (AG024904, 115372, U01 AG024904)
- AstraZeneca
- GlaxoSmithKline
- Novartis (FP7/2007-2013)
- Office of Research and Development
- F. Hoffmann-La Roche (AG024904, U01 AG024904)
- Medpace (U01 AG024904)
- Synarc (U01 AG024904, K01 AG030514)
- South London and Maudsley NHS Foundation Trust
- Wellcome Trust (FP7/2007–2013, 089703, 081864, 115372)
- European Federation of Pharmaceutical Industries and Associations (FP7/20072013, 115372)
- Alzheimer's Society
- Alzheimer's Research Trust
- National Institute for Health and Care Research (115372, NF-SI-0512-10033, FP7/2007–2013, K01 AG030514, U01 AG024904, NF-SI-0512-10135, CL-2011-18-004)
- University of Cambridge
- King's College London
- Newcastle University
- European Commission (U01 AG024904, LSHM_CT_2006_037197, 2007–2013, FP7 2007-2013, FP7/2007, 115372)
- Cardiff University
- Bundesministerium für Bildung und Forschung
- Stichting MS Research
- Elan (U01 AG024904)
- Lundbeckfonden (R165–2013–15320)
- Eisai (U01 AG024904, AG024904)
- North Bristol NHS Trust
- Alfried Krupp von Bohlen und Halbach-Stiftung
- Universitat de Barcelona
- Hersenstichting
- University College London Hospitals NHS Foundation Trust
- H. Lundbeck A/S (U01 AG024904, AG024904)
- Heinz Nixdorf Stiftung
- National Institutes of Health (5rc2ag036502-02, UL1TR001108, FP7/2007-2013, 5r01ag027944-05, 5u01ag024904-10, 7r01ag019757-06, 5r37ag015473-15, AG016976, U01-AG024904, AG024904, AG019610, AG021886, MH60451, U01 AG10483, AG10483, AG013846, UL1TR001445)
- Genentech (AG024904, U01 AG024904)
- Canadian Institutes of Health Research
- Medical Research Council (MR/L023784/2, FP7/20072013, MR/K006584/1, U01 AG024904, MC_PC_13048, MC_UU_12015/2, MR/L501529/1, MR/L010305/1, K01 AG030514, MC_UU_12015/1, MC_G1000734, MR/L023784/1)
- Economic and Social Research Council (ES/L008238/1)
- Menzies Centre for Australian Studies, King's College London, University of London
- Helmholtz Zentrum München
- National Institute on Aging (U01-AG-024904, R01AG017917, AG 10483, P01AG010491, P50 AG016575, AG 016976, AG05 128, P30AG010129, P30AG010133, R01AG019085, P30 AG 08051, P50AG005144, R01AG042611, U01‐AG10483, R01AG33193, P50 AG016576, R01AG030146, AG021547, R01 AG30146, AG036535, AG010491, R01‐AG17917, AG-05144, U24 AG026390, P30AG028383, R01 AG15819, P30AG012300, R01AG041718, AG 025688, P50AG016577, U01-AG-06781, P50AG005133, R01-AG027944, AG 024904, AG 030,514, P30AG028377, U01AG006781, U01AG016976, P50AG005131, R01-AG019757, R37-AG015473, P50AG005138, R01AG026390, AG041718, R01AG022374, P50AG016570, AG019610, K01AG030514, R01AG011101, AG036528, P50AG005128, P30AG010124, P50AG016573, AG019757, R01AG021547, R01AG041232, R01AG030653, U01AG010483, R01AG015819, P30AG008017, P30AG010161, U01AG032984, R01AG012101, CA129769, R01AG031581, P30AG008051, RC2-AG036502, P50AG016582, P50AG008702, AG032984, AG013846, AG-06781, P50AG005681, P50AG005142, P50AG008671, P30AG019610, R01AG026916, P50AG005146, P01 AG0 3991, P01AG003991, 1RC2AG036502, U24AG026395, P30AG013846, P50AG005136, P50AG005134, RC2AG036535, P30AG013854, R01AG025259, P50AG025688, AG026395, R01AG017173, RC2AG036528, R01AG033193, P01AG002219, AG021886, R01AG013616, P30 AG-10133, P01AG019724, U24AG021886, P30AG062421, P50AG023501, AG027944, R01AG020688, AG 030653, P50AG016574, R01AG035137, AG041232)
- National Institute of Mental Health (U01 AG024904, MH60451, R01MH080295, P50MH060451)
- National Human Genome Research Institute (U01HG008657, U01HG004610, U01HG006375)
- National Cancer Institute (R01CA129769, U54CA132378)
- National Institute of Allergy and Infectious Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Neurological Disorders and Stroke (NS3 9764, R01NS059873, MH60451, NIMH MH60451, P50NS039764, FP7/2007-2013)
- National Institute of Environmental Health Sciences (P30ES013508)
- National Institute of Biomedical Imaging and Bioengineering (U01 AG024904, AG024904)
- National Institute of Child Health and Human Development
- National Center for Research Resources (MO1 RR000-96, UL1RR02777, UL1RR029893, M01RR000096)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, modifiable risk factors, systolic blood pressure, smoking, type 2 diabetes, fasting blood glucose, insulin resistance, body mass index, serum lipids, cholesterol, triglycerides, antihypertensive drugs, educational attainment, causal inference, genetic variants, intervention targets, cognitive aging, dementia prevention, cardiovascular risk factors, glycemic traits
- MeSH terms
- Alzheimer Disease, Female, Humans, Male, Risk Factors, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.